We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$741M
AUM Growth
+$38.7M
Cap. Flow
+$31.5M
Cap. Flow %
4.25%
Top 10 Hldgs %
60.64%
Holding
104
New
35
Increased
22
Reduced
3
Closed
10
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$12.3M
2
WAT icon
Waters Corp
WAT
+$9M
3
DO icon
Diamond Offshore Drilling
DO
+$6.09M
4
GILD icon
Gilead Sciences
GILD
+$5.17M
5
RTX icon
RTX Corp
RTX
+$4.82M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Healthcare 24.83%
3 Industrials 11.96%
4 Technology 10.74%
5 Energy 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ISRG icon
26
Intuitive Surgical
ISRG
$150B
$7.27M 0.98%
69,930
– –
2014 Q1
13 quarters
XOM icon
27
ExxonMobil
XOM
$719B
$6.58M 0.89%
81,493
– –
2014 Q1
13 quarters
BIIB icon
28
Biogen
BIIB
$35.3B
$6.17M 0.83%
22,720
+720
+3% +$190K
2015 Q4
6 quarters
DO icon
29
DELISTED
Diamond Offshore Drilling
DO
$6.15M 0.83%
567,700
+457,800
+417% +$6.09M
2014 Q4
10 quarters
USB icon
30
US Bancorp
USB
$89.2B
$5.86M 0.79%
112,900
– –
2016 Q2
4 quarters
CSCO icon
31
Cisco
CSCO
$430B
$5.13M 0.69%
163,890
-71,210
-30% -$2.32M
2014 Q1
13 quarters
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
$4.89M 0.66%
+76,660
New +$4.81M
2017 Q2
0 quarters
MDT icon
33
Medtronic
MDT
$122B
$4.5M 0.61%
50,700
– –
2014 Q1
13 quarters
BDX icon
34
Becton Dickinson
BDX
$52.5B
$4.45M 0.6%
23,370
– –
2014 Q1
13 quarters
CBI
35
DELISTED
Chicago Bridge & Iron Nv
CBI
$4.38M 0.59%
222,000
– –
2014 Q3
11 quarters
BMY icon
36
Bristol-Myers Squibb
BMY
$125B
$3.83M 0.52%
68,700
– –
2016 Q2
4 quarters
GOOG icon
37
Alphabet (Google) Class C
GOOG
$4.21T
$3.54M 0.48%
78,000
– –
2014 Q1
13 quarters
VOO icon
38
Vanguard S&P 500 ETF
VOO
$1.04T
$3M 0.4%
+13,500
New +$2.97M
2017 Q2
0 quarters
SGYP
39
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.23M 0.3%
500,000
+350,000
+233% +$1.44M
2017 Q1
1 quarter
KO icon
40
Coca-Cola
KO
$399B
$2.06M 0.28%
46,000
– –
2014 Q1
13 quarters
BDSI
41
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.68M 0.23%
601,285
+336,675
+127% +$710K
2017 Q1
1 quarter
ACAD icon
42
Acadia Pharmaceuticals
ACAD
$3.39B
$1.67M 0.23%
60,000
– –
2016 Q4
2 quarters
KHC icon
43
The Kraft Heinz Company
KHC
$27.6B
$1.66M 0.22%
19,320
– –
2015 Q3
7 quarters
MCD icon
44
McDonald's
MCD
$173B
$1.54M 0.21%
10,060
– –
2014 Q4
10 quarters
UTHR icon
45
United Therapeutics
UTHR
$23.5B
$1.49M 0.2%
11,490
-8,410
-42% -$1.05M
2016 Q3
3 quarters
AXP icon
46
American Express
AXP
$210B
$1.48M 0.2%
17,600
– –
2014 Q1
13 quarters
JKHY icon
47
Jack Henry & Associates
JKHY
$10.9B
$1.42M 0.19%
+13,700
New +$1.37M
2017 Q2
0 quarters
AMAG
48
DELISTED
AMAG Pharmaceuticals
AMAG
$1.29M 0.17%
70,000
+30,000
+75% +$594K
2017 Q1
1 quarter
MA icon
49
Mastercard
MA
$539B
$1.22M 0.16%
10,000
– –
2014 Q1
13 quarters
BUD icon
50
AB InBev
BUD
$161B
$1.11M 0.15%
10,100
– –
2015 Q3
7 quarters

Similar funds

Hikari Power's Q2 2017 Portfolio in Review

As of Q2 2017, Hikari Power held 104 positions worth $741M, up 5.5% from $703M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power deployed $31.5M of net new capital in Q2 2017, opening 35 new positions and adding to 22 existing holdings. Its largest new stake was Waters Corp: 51,800 shares worth $9.52M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was IBM, an estimated $27.9M trimmed.

  • Hikari Power's largest Q2 2017 buy was Waters Corp: 51,800 shares worth $9.52M.
  • Hikari Power added most to Wabtec in Q2 2017, an estimated $12.3M increase.
  • Hikari Power's biggest Q2 2017 reduction was IBM, cutting an estimated $27.9M.
  • Hikari Power fully exited Ligand Pharmaceuticals in Q2 2017, selling an estimated $1.06M.
  • Hikari Power's ten largest holdings make up 61% of its $741M portfolio in Q2 2017.
  • Hikari Power opened 35 new positions and closed 10 in Q2 2017.
  • Hikari Power's portfolio value rose 5.5% quarter-over-quarter to $741M.

Based on Hikari Power's 13F filing for Q2 2017, filed 9 Aug 2017.